Category: Business

Visioneering Technologies, Inc. Expands US Sales Force

ATLANTA–(BUSINESS WIRE)–Visioneering Technologies, Inc. (ASX: VTI), a US-based medical device company (‘Visioneering’ or ‘The Company’) engaged in the design, manufacture, sale and distribution of its proprietary NaturalVue® Multifocal 1 Day Contact Lenses, is pleased to announce the recent expansion of its US sales force. In line with Visioneering’s plan to broaden and accelerate its US launch of NaturalVue Multifocal Contact Lenses, they have appointed Mr. Joshua Suarez as new District Sale

Second Sight Reports First Quarter 2017 Financial Results

SYLMAR, Calif.–(BUSINESS WIRE)–Second Sight Medical Products, Inc. (NASDAQ:EYES) (“Second Sight” or “the Company”), a developer, manufacturer and marketer of implantable visual prosthetics to provide some useful vision to blind patients, today reported financial results for the three-months ended March 31, 2017. First Quarter 2017 and Recent Company Highlights: Increased implant volume to 14 Argus® II Retinal Prosthesis Systems (“Argus II”) worldwide during the first quarter of 2017 compared

Global AR & VR Smartglasses and Functional Contact Lenses Market Research Report 2017-2027 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “AR & VR Smartglasses and Functional Contact Lenses 2017-2027” report to their offering. AR & VR Smartglasses and Functional Contact Lenses Market will be Worth Over $26 Billion by 2027. This new report is focused on how the market for AR and VR headsets is going to evolve in the next decade, based on the exciting research and developments efforts of recent years along with the high visibility some projects

Bio-Tissue Announces Global Online Purchase Availability for Cliradex Light & Website Relaunch

MIAMI–(BUSINESS WIRE)–Bio-Tissue, a business unit of TissueTech, Inc., today announced the global online availability of its newest product Cliradex Light advanced foaming eyelid cleanser on its newly redesigned website, www.cliradex.com. International purchases may be directed to Amazon Marketplace. Cliradex Light – which was launched last year and quickly realized high consumer and physician office demand – is ideal for preventative eyelid care, everyday ocular hygiene and mild-to-moderate

Glaukos Completes Patient Enrollment in Phase II Clinical Trial for iDose™ Travoprost Intraocular Implant in Glaucoma Patients

SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma, today announced the completion of patient enrollment in the U.S. Investigational New Drug (IND) Phase II study of its Travoprost Intraocular Implant with the iDose™ delivery system in patients with glaucoma. Implanted during a micro-invasive proce

Global Wet Age Related Macular Degeneration (AMD) Market Analysis & Outlook 2017-2021 – Research and Markets

DUBLIN–(BUSINESS WIRE)–Research and Markets has announced the addition of the “Global Wet Age Related Macular Degeneration (AMD) Market: Industry Analysis & Outlook (2017-2021)” report to their offering. “Global Wet AMD Market: Industry Analysis & Outlook (2017-2021)” analyses the development of this market, with focus on the U.S. and outside the U.S. markets. The major trends, growth drivers as well as issues being faced by the market are discussed in detail in this report. The four

Optovue est la première entreprise à lancer sur le marché l’angiographie OCT haute densité en ophtalmologie

FREMONT, Californie–(BUSINESS WIRE)–Optovue, le leader mondial dans le développement de la tomographie par cohérence optique (OCT, Optical Coherence Tomography) et de l’angiographie OCT (OCTA, OCT Angiography ), est la première entreprise à proposer des images OCTA de densité supérieure qui apportent des améliorations significatives dans la résolution et la visualisation périphérique de la circulation vasculaire de l’œil. L’imagerie AngioVueHD, qui est distribuée commercialement par Optovue a

Optovue veröffentlicht als erster Anbieter eine OCT-Angiografie mit hoher Dichte für die Augenheilkunde (Ophthalmologie)

FREMONT, Kalifornien (USA)–(BUSINESS WIRE)–Optovue, der weltweit führende Entwickler von optischer Kohärenztomografie (OCT) und OCT-Angiografie (OCTA), ist das erste Unternehmen, das OCTA-Bildgebung mit höherer Dichte anbietet. Sie sorgt für eine maßgebliche Verbesserung der Auflösung und peripheren Visualisierung der Gefäßanordnung im Auge. Die AngioVueHD-Bildgebung, die heute von Optovue in den Handel gegeben wurde, liefert OCTA-Scans mit 73 Prozent mehr Abtastpunkten* und verbessert die Bi

Riassunto: Optovue lancia per prima l’angiografia OCT per applicazioni oftalmologiche

FREMONT, California–(BUSINESS WIRE)–Optovue, leader globale nello sviluppo della tomografia a coerenza ottica (optical coherence tomography, OCT) e dell’angiografia OCT (OCT angiography, OCTA), è la prima azienda a offrire l’imaging OCTA ad alta densità, che consente un miglioramento significativo in termini di risoluzione e visualizzazione della vascolarizzazione periferica dell’occhio. L’imaging AngioVueHD, lanciata oggi sul mercato da Optovue, offre scansioni OCTA con il 73% di punti di ca